Clinical Trial Update: Evaluation of 2 Intensification Treatment Strategies for Neuroblastoma Patients With a Poor Response to Induction [Phase 2]

View source ↗

Summary

This update reports a Phase 2 trial evaluating two intensified treatment strategies for patients with very high-risk neuroblastoma who had a poor response to in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Very High Risk Neuroblastoma | Phase 2 | Status: TERMINATED